St Vincent's Hospital, Sydney
Clinical trials sponsored by St Vincent's Hospital, Sydney, explained in plain language.
-
Hormone boost plus chemo aims to shrink hard-to-treat prostate cancer
Disease control Recruiting nowThis study tests whether a high dose of testosterone combined with the chemotherapy drug carboplatin can help men with a specific type of advanced prostate cancer that has stopped responding to standard hormone therapy. About 30 men with a genetic defect called homologous recombi…
Phase: PHASE2 • Sponsor: St Vincent's Hospital, Sydney • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC
-
New combo aims to boost immune attack on eye cancer
Disease control Recruiting nowThis early-phase study tests whether adding a new drug (roginolisib) to an existing treatment (tebentafusp) is safe and tolerable for people with advanced uveal melanoma, a rare eye cancer. The study enrolls 8 adults who are already receiving tebentafusp as their first treatment.…
Phase: PHASE1 • Sponsor: St Vincent's Hospital, Sydney • Aim: Disease control
Last updated Jun 08, 2026 13:09 UTC
-
What do men think about breast side effects? new study seeks answers
Knowledge-focused Recruiting nowThis study talks to men with prostate cancer to learn how they feel about the risk of breast-related side effects, like breast growth, from their treatment. The goal is to understand what matters most to them when choosing treatments. The results will help doctors and patients ma…
Phase: NA • Sponsor: St Vincent's Hospital, Sydney • Aim: Knowledge-focused
Last updated Jun 08, 2026 13:07 UTC